Abbott launches Next-Gen FreeStyle Libre 2 Plus in Việt Nam


Global healthcare leader Abbott on June 24 launched its FreeStyle Libre 2 Plus Flash Glucose Monitoring System Sensor, with real-time minute-by-minute glucose readings, in Việt Nam.

 

With integrated continuous glucose monitoring (iCGM) standards and customisable alarms, FreeStyle Libre 2 Plus sensor gives peace of mind to people with diabetes and caregivers. — Photo courtesy of Abbott

HCM CITY — Global healthcare leader Abbott launched its FreeStyle Libre 2 Plus Flash Glucose Monitoring System Sensor, with real-time minute-by-minute glucose readings, in Việt Nam on June 24.

With this sensor, people living with diabetes can see their glucose readings and receive alerts automatically on their readers when their glucose reaches levels that are either too low or too high.

“The world-leading FreeStyle Libre system empowers people living with diabetes to make informed health decisions," said Douglas Kuo, Divisional Vice President at Abbott Vietnam, Australia and New Zealand.

“By providing real-time glucose readings and optional alarms, our FreeStyle Libre 2 Plus sensor simplifies diabetes management, so they can spend more time enjoying the freedom of doing the things they love.”

FreeStyle Libre 2 Plus provides highly accurate glucose data. — Photo courtesy of Abbott

More than seven million people are living with diabetes in Việt Nam, with a growing number of patients using continuous glucose monitors to improve their daily diabetes management. This presents a significant opportunity to provide the transformative benefits of continuous glucose monitors, like the FreeStyle Libre 2 Plus sensor.

The FreeStyle Libre 2 Plus sensor's performance meets robust accuracy standards, delivering reliable glucose readings for users. With glucose readings on display, people can see the impact of food, medication and exercise on their glucose levels and take appropriate action.

Studies demonstrate that FreeStyle Libre technology helps reduce low blood sugar episodes and lower HbA1c levels by nearly 1 per cent. The system has also been shown to reduce hospital visits by up to two-thirds and cut work absence by nearly 60 per cent.

Utilising Bluetooth technology and optional alarms, the FreeStyle Libre 2 Plus sensor provides continuous glucose data to the reader. After scanning the sensor worn on the back of the upper arm for up to 15 days, people living with diabetes see real-time glucose levels, historical trends and patterns, and arrows showing where glucose levels are going without having to use a fingerstick. 

CGM is recommended for early use in people with diabetes. — Photo courtesy of Abbott

The system includes the FreeStyle Libre 2 Plus sensor and the FreeStyle Libre 2 reader. It is available for people aged two years and older with or without diabetes, including women with gestational diabetes.

In Việt Nam, they are distributed through Abbott’s official store on e-commerce platforms, Abbott’s careline at 19001519 and the Pharmacity pharmacy chain.

Abbott continues to pioneer groundbreaking technology to support people living with diabetes. The company revolutionised diabetes care 10 years ago with its world-leading FreeStyle Libre continuous glucose monitoring portfolio, which today is used by approximately eight million people across over 60 countries.

People use Libre technology to see their glucose numbers in real time, providing insights into how food, activity or insulin impacts their glucose to help them make progress on their health goals. There is full or partial reimbursement for Libre systems in more than 40 countries.

Abbott is a global healthcare leader that helps people live more fully at all stages of life. Our portfolio of life-changing technologies spans the spectrum of healthcare, with leading businesses and products in diagnostics, medical devices, nutritionals and branded generic medicines. Abbott has been in Việt Nam for over 30 years and focuses on helping Vietnamese people live their best lives through the power of good health. — VNS

  • Share: